Emerald Health, the makers of the popular and widely used epinephrine auto-injector, has released the first-ever treatment for an epileptic condition known as refractory encephalopathy (FE), which affects about 20% of Americans.Emerald Health, which has a patent for the drug, will begin to distribute the EpiPen to patients this week, the company said.It also said […]

Continue Reading...